Article
HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru.
Journal of the International AIDS Society - 1 Nov 2019
Trebelcock William L, Lama Javier R, Duerr Ann, Sanchez Hugo, Cabello Robinson, Gilada Trupti, Segura Patricia, Reisner Sari L, Mayer Kenneth H, Mullins James, Bender Ignacio Rachel A
Abstract excerpt
INTRODUCTION: Transmitted, or any pretreatment drug resistance (TDR, PDR) can compromise efficacy of first-line antiretroviral therapy (ART). In Peru, genotypic resistance testing is not routinely performed before ART initiation, and estimated PDR prevalence prior to 2012 ranged from 1.0% to 4.7%. We aimed to update estimates of PDR prevalence in men who have sex with men (cis-MSM) and transgender women (TW)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
